In the body, it serves as a means of transport for the long-chain fatty acids into the mitochondria, the site of fat burning, where vital energy is obtained from the fats
[6] Meanwhile, the kidneys were quietly rewriting their own chapter
The abdomen is the most common
Figure 3 6 Conclusion In summary, tirzepatide, a dual agonist of the GLP-1 and GIP receptors, shows promising potential for the management of obesity-related OSAS by promoting weight loss, improving metabolic function, and modulating inflammatory pathways
Support for Muscle Recovery and Immunity Beyond the gut, glutamine is a favorite among athletes and active individuals
PP-TR-IN-0580 | 29th July 2025 Eli Lilly and Company